Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-13
DOI
10.3389/fonc.2018.00521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic modifiers as new immunomodulatory therapies in solid tumours
- (2018) S Aspeslagh et al. ANNALS OF ONCOLOGY
- Computational characterization of suppressive immune microenvironments in glioblastoma
- (2018) Suvi Luoto et al. CANCER RESEARCH
- LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway
- (2018) Zhigang Xiao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Long noncoding RNAs in cancer-immunity cycle
- (2018) Wei-Di Yu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy
- (2018) Changhong Liu et al. Journal of Hematology & Oncology
- Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
- (2018) Sze Kiat Tan et al. Molecular Cancer
- Improved molecular karyotyping in Glioblastoma
- (2018) Ian E. Burbulis et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Comparison of glioblastoma (GBM) molecular classification methods
- (2018) Eunjee Lee et al. SEMINARS IN CANCER BIOLOGY
- The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma
- (2018) Ana Xavier-Magalhães et al. Oncotarget
- HOTAIR Is a Potential Novel Biomarker in Patients with Congenital Heart Diseases
- (2018) Yu Jiang et al. Biomed Research International
- The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma
- (2018) Joseph DiDomenico et al. OncoImmunology
- 18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors
- (2018) Angelo Castello et al. LEUKEMIA & LYMPHOMA
- Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma
- (2018) Bingxi Lei et al. Journal of Neurological Surgery Part A-Central European Neurosurgery
- LncRNA Structural Characteristics in Epigenetic Regulation
- (2017) Chenguang Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HOTAIR upregulates an 18-gene cell cycle-related mRNA network in glioma
- (2017) Kai Huang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma
- (2017) Jie Shen et al. MOLECULAR CARCINOGENESIS
- CNS cancer: Glioblastoma subtypes revisited
- (2017) Peter Sidaway Nature Reviews Clinical Oncology
- IMMU-16. EFFECT OF ANTI-PD-1 THERAPY COMBINATION ON TEMOZOLOMIDE IN MOUSE GLIOBLASTOMA
- (2017) Junseong Park et al. NEURO-ONCOLOGY
- Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
- (2017) Andrew S. Venteicher et al. SCIENCE
- Advances in epigenetic glioblastoma therapy
- (2017) Dong Hoon Lee et al. Oncotarget
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
- (2017) Roberta Mazzone et al. Clinical Epigenetics
- Analysis of dysregulated long non-coding RNA expressions in glioblastoma cells
- (2016) Tugce Balci et al. GENE
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
- (2015) Chiara Pastori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HOTAIR is a therapeutic target in glioblastoma
- (2015) Xuan Zhou et al. Oncotarget
- Vorinostat-An overview
- (2015) AdityaKumar Bubna INDIAN JOURNAL OF DERMATOLOGY
- Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis
- (2015) Karrie Kiang et al. Cancers
- Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited
- (2015) Nicola Montano et al. NEOPLASIA
- Emerging Therapies for Glioblastoma
- (2014) Alissa A. Thomas et al. JAMA Neurology
- Using the molecular classification of glioblastoma to inform personalized treatment
- (2013) Adriana Olar et al. JOURNAL OF PATHOLOGY
- Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
- (2012) X. Yao et al. BLOOD
- Long non-coding RNA modifies chromatin
- (2011) Alka Saxena et al. BIOESSAYS
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- T-cell exhaustion: characteristics, causes and conversion
- (2010) John S. Yi et al. IMMUNOLOGY
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for Intervention
- (2009) William Humphries et al. NEUROSURGERY CLINICS OF NORTH AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now